Matthew J Budoff
Matthew J Budoff is an expert in Cardiology at Harbor–UCLA Medical Center (United States). As of October 2026, ScienceLeadR ranks Matthew J Budoff in the top 1% of experts worldwide for Arterial Occlusive Diseases, Arteriosclerosis and Coronary Disease. Matthew J Budoff has authored 2,748 publications, the most recent in 2026, and is an investigator in 68 clinical trials, 6 of them ongoing. SLR score: 9,522 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Medical Imaging - Public Health - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
- Top Arterial Occlusive Diseases key opinion leaders — ranked #1
- Top Arteriosclerosis key opinion leaders — ranked #1
- Top Coronary Disease key opinion leaders — ranked #6
- Top Myocardial Ischemia key opinion leaders
- Top Glucose Metabolism Disorders key opinion leaders
- Top Diabetes Mellitus key opinion leaders
Organizations
Career arc: 1995 - 2026
Number : 2748
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 68
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 17
Ongoing Clinical Trials
6 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis NCT07521007 — safety, coronary artery disease, arteries, atherosclerosis | Phase 2 | Recruiting | 2026 |
| Efficacy Safety and PopPK Profile of ABP 745 in Patients With Atherosclerosis NCT07303777 — safety, cardiovascular diseases, tablets, atherosclerosis, pharmacokinetics | Phase 2 | Recruiting | 2026 |
| Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease NCT06342609 — myocardial ischemia, coronary artery disease, colchicine, arteries, coronary disease, atherosclerosis, ischemia | Phase 4 | Active not recruiting | 2023 |
| A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib Ezetimibe on Coronary Plaque NCT06305559 — ezetimibe, hyperlipidemias, coronary artery disease, cardiovascular diseases, angiography, arteries, therapeutics, plaque, atherosclerotic, computed tomography angiography, lipids | Phase 3 | Active not recruiting | 2024 |
| Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT NCT05708859 — diabetes mellitus, myocardial ischemia, coronary artery disease, arteries, solutions, atherosclerosis, ischemia, diabetes mellitus, type 2 | Phase 4 | Recruiting | 2024 |
LeadR Networks
Main global connection map